nodes	percent_of_prediction	percent_of_DWPC	metapath
Betaxolol—CYP2D6—epilepsy syndrome	0.308	1	CbGaD
Betaxolol—CYP1A2—Carbamazepine—epilepsy syndrome	0.0449	0.178	CbGbCtD
Betaxolol—CYP1A2—Primidone—epilepsy syndrome	0.0419	0.166	CbGbCtD
Betaxolol—CYP1A2—Propofol—epilepsy syndrome	0.0376	0.149	CbGbCtD
Betaxolol—CYP1A2—Phenobarbital—epilepsy syndrome	0.0359	0.142	CbGbCtD
Betaxolol—CYP1A2—Diazepam—epilepsy syndrome	0.034	0.135	CbGbCtD
Betaxolol—CYP2D6—Propofol—epilepsy syndrome	0.031	0.123	CbGbCtD
Betaxolol—CYP1A2—Valproic Acid—epilepsy syndrome	0.0268	0.106	CbGbCtD
Betaxolol—Chlorphenesin—BCHE—epilepsy syndrome	0.000584	0.152	CrCbGaD
Betaxolol—Metoprolol—CYP2C19—epilepsy syndrome	0.000337	0.0876	CrCbGaD
Betaxolol—Bisoprolol—CYP2D6—epilepsy syndrome	0.000312	0.0812	CrCbGaD
Betaxolol—Acebutolol—CYP2D6—epilepsy syndrome	0.000296	0.0769	CrCbGaD
Betaxolol—Oxprenolol—CYP2D6—epilepsy syndrome	0.000294	0.0764	CrCbGaD
Betaxolol—Chlorphenesin—PTGS2—epilepsy syndrome	0.000269	0.07	CrCbGaD
Betaxolol—Alprenolol—CYP2D6—epilepsy syndrome	0.000268	0.0698	CrCbGaD
Betaxolol—Metoprolol—CYP2D6—epilepsy syndrome	0.00025	0.0649	CrCbGaD
Betaxolol—Pindolol—CYP2D6—epilepsy syndrome	0.000231	0.0601	CrCbGaD
Betaxolol—Atenolol—ABCB1—epilepsy syndrome	0.000229	0.0595	CrCbGaD
Betaxolol—Acebutolol—ABCB1—epilepsy syndrome	0.000211	0.0549	CrCbGaD
Betaxolol—Metoprolol—ABCB1—epilepsy syndrome	0.000178	0.0464	CrCbGaD
Betaxolol—Propranolol—CYP2C19—epilepsy syndrome	0.00017	0.0442	CrCbGaD
Betaxolol—Propranolol—CYP2D6—epilepsy syndrome	0.000126	0.0328	CrCbGaD
Betaxolol—Propranolol—ABCB1—epilepsy syndrome	9e-05	0.0234	CrCbGaD
Betaxolol—Pruritus—Phenytoin—epilepsy syndrome	5.9e-05	0.000164	CcSEcCtD
Betaxolol—Nausea—Levetiracetam—epilepsy syndrome	5.9e-05	0.000164	CcSEcCtD
Betaxolol—Rash—Vigabatrin—epilepsy syndrome	5.89e-05	0.000164	CcSEcCtD
Betaxolol—Dizziness—Felbamate—epilepsy syndrome	5.89e-05	0.000164	CcSEcCtD
Betaxolol—Dermatitis—Vigabatrin—epilepsy syndrome	5.89e-05	0.000164	CcSEcCtD
Betaxolol—Pruritus—Oxcarbazepine—epilepsy syndrome	5.87e-05	0.000163	CcSEcCtD
Betaxolol—Hypersensitivity—Carbamazepine—epilepsy syndrome	5.87e-05	0.000163	CcSEcCtD
Betaxolol—Vision blurred—Gabapentin—epilepsy syndrome	5.85e-05	0.000163	CcSEcCtD
Betaxolol—Headache—Vigabatrin—epilepsy syndrome	5.85e-05	0.000163	CcSEcCtD
Betaxolol—Vomiting—Diazepam—epilepsy syndrome	5.85e-05	0.000163	CcSEcCtD
Betaxolol—Anorexia—Valproic Acid—epilepsy syndrome	5.83e-05	0.000162	CcSEcCtD
Betaxolol—Tremor—Gabapentin—epilepsy syndrome	5.82e-05	0.000162	CcSEcCtD
Betaxolol—Rash—Diazepam—epilepsy syndrome	5.8e-05	0.000161	CcSEcCtD
Betaxolol—Dermatitis—Diazepam—epilepsy syndrome	5.79e-05	0.000161	CcSEcCtD
Betaxolol—Visual impairment—Topiramate—epilepsy syndrome	5.79e-05	0.000161	CcSEcCtD
Betaxolol—Arthralgia—Pregabalin—epilepsy syndrome	5.77e-05	0.00016	CcSEcCtD
Betaxolol—Chest pain—Pregabalin—epilepsy syndrome	5.77e-05	0.00016	CcSEcCtD
Betaxolol—Myalgia—Pregabalin—epilepsy syndrome	5.77e-05	0.00016	CcSEcCtD
Betaxolol—Ill-defined disorder—Gabapentin—epilepsy syndrome	5.76e-05	0.00016	CcSEcCtD
Betaxolol—Dizziness—Zonisamide—epilepsy syndrome	5.76e-05	0.00016	CcSEcCtD
Betaxolol—Headache—Diazepam—epilepsy syndrome	5.76e-05	0.00016	CcSEcCtD
Betaxolol—Anxiety—Pregabalin—epilepsy syndrome	5.75e-05	0.00016	CcSEcCtD
Betaxolol—Diarrhoea—Clonazepam—epilepsy syndrome	5.75e-05	0.00016	CcSEcCtD
Betaxolol—Anaemia—Gabapentin—epilepsy syndrome	5.74e-05	0.00016	CcSEcCtD
Betaxolol—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	5.73e-05	0.000159	CcSEcCtD
Betaxolol—Hypotension—Valproic Acid—epilepsy syndrome	5.71e-05	0.000159	CcSEcCtD
Betaxolol—Asthenia—Carbamazepine—epilepsy syndrome	5.71e-05	0.000159	CcSEcCtD
Betaxolol—Diarrhoea—Phenytoin—epilepsy syndrome	5.71e-05	0.000159	CcSEcCtD
Betaxolol—Discomfort—Pregabalin—epilepsy syndrome	5.7e-05	0.000158	CcSEcCtD
Betaxolol—Nausea—Fosphenytoin—epilepsy syndrome	5.69e-05	0.000158	CcSEcCtD
Betaxolol—Diarrhoea—Oxcarbazepine—epilepsy syndrome	5.68e-05	0.000158	CcSEcCtD
Betaxolol—Hypersensitivity—Lamotrigine—epilepsy syndrome	5.67e-05	0.000158	CcSEcCtD
Betaxolol—Vomiting—Felbamate—epilepsy syndrome	5.66e-05	0.000157	CcSEcCtD
Betaxolol—Dry mouth—Pregabalin—epilepsy syndrome	5.64e-05	0.000157	CcSEcCtD
Betaxolol—Pruritus—Carbamazepine—epilepsy syndrome	5.63e-05	0.000157	CcSEcCtD
Betaxolol—Rash—Felbamate—epilepsy syndrome	5.61e-05	0.000156	CcSEcCtD
Betaxolol—Eye disorder—Topiramate—epilepsy syndrome	5.61e-05	0.000156	CcSEcCtD
Betaxolol—Dermatitis—Felbamate—epilepsy syndrome	5.61e-05	0.000156	CcSEcCtD
Betaxolol—Malaise—Gabapentin—epilepsy syndrome	5.6e-05	0.000156	CcSEcCtD
Betaxolol—Tinnitus—Topiramate—epilepsy syndrome	5.6e-05	0.000156	CcSEcCtD
Betaxolol—Vertigo—Gabapentin—epilepsy syndrome	5.58e-05	0.000155	CcSEcCtD
Betaxolol—Headache—Felbamate—epilepsy syndrome	5.58e-05	0.000155	CcSEcCtD
Betaxolol—Confusional state—Pregabalin—epilepsy syndrome	5.57e-05	0.000155	CcSEcCtD
Betaxolol—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	5.57e-05	0.000155	CcSEcCtD
Betaxolol—Flushing—Topiramate—epilepsy syndrome	5.57e-05	0.000155	CcSEcCtD
Betaxolol—Cardiac disorder—Topiramate—epilepsy syndrome	5.57e-05	0.000155	CcSEcCtD
Betaxolol—Syncope—Gabapentin—epilepsy syndrome	5.57e-05	0.000155	CcSEcCtD
Betaxolol—Dizziness—Clonazepam—epilepsy syndrome	5.55e-05	0.000154	CcSEcCtD
Betaxolol—Nausea—Vigabatrin—epilepsy syndrome	5.55e-05	0.000154	CcSEcCtD
Betaxolol—Vomiting—Zonisamide—epilepsy syndrome	5.54e-05	0.000154	CcSEcCtD
Betaxolol—Insomnia—Valproic Acid—epilepsy syndrome	5.53e-05	0.000154	CcSEcCtD
Betaxolol—Oedema—Pregabalin—epilepsy syndrome	5.53e-05	0.000154	CcSEcCtD
Betaxolol—Asthenia—Lamotrigine—epilepsy syndrome	5.52e-05	0.000154	CcSEcCtD
Betaxolol—Dizziness—Phenytoin—epilepsy syndrome	5.52e-05	0.000153	CcSEcCtD
Betaxolol—Rash—Zonisamide—epilepsy syndrome	5.49e-05	0.000153	CcSEcCtD
Betaxolol—Infection—Pregabalin—epilepsy syndrome	5.49e-05	0.000153	CcSEcCtD
Betaxolol—Paraesthesia—Valproic Acid—epilepsy syndrome	5.49e-05	0.000153	CcSEcCtD
Betaxolol—Palpitations—Gabapentin—epilepsy syndrome	5.49e-05	0.000153	CcSEcCtD
Betaxolol—Dermatitis—Zonisamide—epilepsy syndrome	5.49e-05	0.000153	CcSEcCtD
Betaxolol—Dizziness—Oxcarbazepine—epilepsy syndrome	5.49e-05	0.000153	CcSEcCtD
Betaxolol—Nausea—Diazepam—epilepsy syndrome	5.46e-05	0.000152	CcSEcCtD
Betaxolol—Loss of consciousness—Gabapentin—epilepsy syndrome	5.46e-05	0.000152	CcSEcCtD
Betaxolol—Headache—Zonisamide—epilepsy syndrome	5.46e-05	0.000152	CcSEcCtD
Betaxolol—Dyspnoea—Valproic Acid—epilepsy syndrome	5.45e-05	0.000152	CcSEcCtD
Betaxolol—Diarrhoea—Carbamazepine—epilepsy syndrome	5.45e-05	0.000152	CcSEcCtD
Betaxolol—Angiopathy—Topiramate—epilepsy syndrome	5.45e-05	0.000151	CcSEcCtD
Betaxolol—Pruritus—Lamotrigine—epilepsy syndrome	5.44e-05	0.000151	CcSEcCtD
Betaxolol—Shock—Pregabalin—epilepsy syndrome	5.44e-05	0.000151	CcSEcCtD
Betaxolol—Immune system disorder—Topiramate—epilepsy syndrome	5.42e-05	0.000151	CcSEcCtD
Betaxolol—Nervous system disorder—Pregabalin—epilepsy syndrome	5.42e-05	0.000151	CcSEcCtD
Betaxolol—Cough—Gabapentin—epilepsy syndrome	5.42e-05	0.000151	CcSEcCtD
Betaxolol—Thrombocytopenia—Pregabalin—epilepsy syndrome	5.41e-05	0.000151	CcSEcCtD
Betaxolol—Mediastinal disorder—Topiramate—epilepsy syndrome	5.41e-05	0.00015	CcSEcCtD
Betaxolol—Tachycardia—Pregabalin—epilepsy syndrome	5.4e-05	0.00015	CcSEcCtD
Betaxolol—Chills—Topiramate—epilepsy syndrome	5.39e-05	0.00015	CcSEcCtD
Betaxolol—Dyspepsia—Valproic Acid—epilepsy syndrome	5.38e-05	0.00015	CcSEcCtD
Betaxolol—Skin disorder—Pregabalin—epilepsy syndrome	5.37e-05	0.000149	CcSEcCtD
Betaxolol—Hyperhidrosis—Pregabalin—epilepsy syndrome	5.34e-05	0.000149	CcSEcCtD
Betaxolol—Vomiting—Clonazepam—epilepsy syndrome	5.34e-05	0.000148	CcSEcCtD
Betaxolol—Decreased appetite—Valproic Acid—epilepsy syndrome	5.32e-05	0.000148	CcSEcCtD
Betaxolol—Alopecia—Topiramate—epilepsy syndrome	5.31e-05	0.000148	CcSEcCtD
Betaxolol—Vomiting—Phenytoin—epilepsy syndrome	5.3e-05	0.000148	CcSEcCtD
Betaxolol—Rash—Clonazepam—epilepsy syndrome	5.3e-05	0.000147	CcSEcCtD
Betaxolol—Dermatitis—Clonazepam—epilepsy syndrome	5.29e-05	0.000147	CcSEcCtD
Betaxolol—Myalgia—Gabapentin—epilepsy syndrome	5.29e-05	0.000147	CcSEcCtD
Betaxolol—Arthralgia—Gabapentin—epilepsy syndrome	5.29e-05	0.000147	CcSEcCtD
Betaxolol—Chest pain—Gabapentin—epilepsy syndrome	5.29e-05	0.000147	CcSEcCtD
Betaxolol—Nausea—Felbamate—epilepsy syndrome	5.29e-05	0.000147	CcSEcCtD
Betaxolol—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	5.28e-05	0.000147	CcSEcCtD
Betaxolol—Vomiting—Oxcarbazepine—epilepsy syndrome	5.28e-05	0.000147	CcSEcCtD
Betaxolol—Fatigue—Valproic Acid—epilepsy syndrome	5.27e-05	0.000147	CcSEcCtD
Betaxolol—Anxiety—Gabapentin—epilepsy syndrome	5.27e-05	0.000147	CcSEcCtD
Betaxolol—Anorexia—Pregabalin—epilepsy syndrome	5.27e-05	0.000147	CcSEcCtD
Betaxolol—Dizziness—Carbamazepine—epilepsy syndrome	5.27e-05	0.000146	CcSEcCtD
Betaxolol—Diarrhoea—Lamotrigine—epilepsy syndrome	5.27e-05	0.000146	CcSEcCtD
Betaxolol—Headache—Clonazepam—epilepsy syndrome	5.26e-05	0.000146	CcSEcCtD
Betaxolol—Rash—Phenytoin—epilepsy syndrome	5.26e-05	0.000146	CcSEcCtD
Betaxolol—Mental disorder—Topiramate—epilepsy syndrome	5.26e-05	0.000146	CcSEcCtD
Betaxolol—Dermatitis—Phenytoin—epilepsy syndrome	5.26e-05	0.000146	CcSEcCtD
Betaxolol—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	5.25e-05	0.000146	CcSEcCtD
Betaxolol—Rash—Oxcarbazepine—epilepsy syndrome	5.23e-05	0.000145	CcSEcCtD
Betaxolol—Pain—Valproic Acid—epilepsy syndrome	5.23e-05	0.000145	CcSEcCtD
Betaxolol—Constipation—Valproic Acid—epilepsy syndrome	5.23e-05	0.000145	CcSEcCtD
Betaxolol—Dermatitis—Oxcarbazepine—epilepsy syndrome	5.23e-05	0.000145	CcSEcCtD
Betaxolol—Headache—Phenytoin—epilepsy syndrome	5.23e-05	0.000145	CcSEcCtD
Betaxolol—Malnutrition—Topiramate—epilepsy syndrome	5.23e-05	0.000145	CcSEcCtD
Betaxolol—Erythema—Topiramate—epilepsy syndrome	5.23e-05	0.000145	CcSEcCtD
Betaxolol—Discomfort—Gabapentin—epilepsy syndrome	5.23e-05	0.000145	CcSEcCtD
Betaxolol—Headache—Oxcarbazepine—epilepsy syndrome	5.2e-05	0.000145	CcSEcCtD
Betaxolol—Nausea—Zonisamide—epilepsy syndrome	5.18e-05	0.000144	CcSEcCtD
Betaxolol—Dry mouth—Gabapentin—epilepsy syndrome	5.17e-05	0.000144	CcSEcCtD
Betaxolol—Hypotension—Pregabalin—epilepsy syndrome	5.17e-05	0.000144	CcSEcCtD
Betaxolol—Tension—Topiramate—epilepsy syndrome	5.13e-05	0.000143	CcSEcCtD
Betaxolol—Dysgeusia—Topiramate—epilepsy syndrome	5.12e-05	0.000142	CcSEcCtD
Betaxolol—Confusional state—Gabapentin—epilepsy syndrome	5.11e-05	0.000142	CcSEcCtD
Betaxolol—Dizziness—Lamotrigine—epilepsy syndrome	5.09e-05	0.000142	CcSEcCtD
Betaxolol—Nervousness—Topiramate—epilepsy syndrome	5.08e-05	0.000141	CcSEcCtD
Betaxolol—Oedema—Gabapentin—epilepsy syndrome	5.07e-05	0.000141	CcSEcCtD
Betaxolol—Vomiting—Carbamazepine—epilepsy syndrome	5.06e-05	0.000141	CcSEcCtD
Betaxolol—Feeling abnormal—Valproic Acid—epilepsy syndrome	5.04e-05	0.00014	CcSEcCtD
Betaxolol—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	5.04e-05	0.00014	CcSEcCtD
Betaxolol—Infection—Gabapentin—epilepsy syndrome	5.04e-05	0.00014	CcSEcCtD
Betaxolol—Muscle spasms—Topiramate—epilepsy syndrome	5.02e-05	0.00014	CcSEcCtD
Betaxolol—Rash—Carbamazepine—epilepsy syndrome	5.02e-05	0.00014	CcSEcCtD
Betaxolol—Dermatitis—Carbamazepine—epilepsy syndrome	5.02e-05	0.000139	CcSEcCtD
Betaxolol—Insomnia—Pregabalin—epilepsy syndrome	5e-05	0.000139	CcSEcCtD
Betaxolol—Nausea—Clonazepam—epilepsy syndrome	4.99e-05	0.000139	CcSEcCtD
Betaxolol—Headache—Carbamazepine—epilepsy syndrome	4.99e-05	0.000139	CcSEcCtD
Betaxolol—Shock—Gabapentin—epilepsy syndrome	4.99e-05	0.000139	CcSEcCtD
Betaxolol—Nervous system disorder—Gabapentin—epilepsy syndrome	4.97e-05	0.000138	CcSEcCtD
Betaxolol—Paraesthesia—Pregabalin—epilepsy syndrome	4.96e-05	0.000138	CcSEcCtD
Betaxolol—Thrombocytopenia—Gabapentin—epilepsy syndrome	4.96e-05	0.000138	CcSEcCtD
Betaxolol—Nausea—Phenytoin—epilepsy syndrome	4.96e-05	0.000138	CcSEcCtD
Betaxolol—Tachycardia—Gabapentin—epilepsy syndrome	4.95e-05	0.000138	CcSEcCtD
Betaxolol—Dyspnoea—Pregabalin—epilepsy syndrome	4.93e-05	0.000137	CcSEcCtD
Betaxolol—Nausea—Oxcarbazepine—epilepsy syndrome	4.93e-05	0.000137	CcSEcCtD
Betaxolol—Vision blurred—Topiramate—epilepsy syndrome	4.93e-05	0.000137	CcSEcCtD
Betaxolol—Skin disorder—Gabapentin—epilepsy syndrome	4.92e-05	0.000137	CcSEcCtD
Betaxolol—Hyperhidrosis—Gabapentin—epilepsy syndrome	4.9e-05	0.000136	CcSEcCtD
Betaxolol—Tremor—Topiramate—epilepsy syndrome	4.9e-05	0.000136	CcSEcCtD
Betaxolol—Vomiting—Lamotrigine—epilepsy syndrome	4.89e-05	0.000136	CcSEcCtD
Betaxolol—Urticaria—Valproic Acid—epilepsy syndrome	4.86e-05	0.000135	CcSEcCtD
Betaxolol—Rash—Lamotrigine—epilepsy syndrome	4.85e-05	0.000135	CcSEcCtD
Betaxolol—Ill-defined disorder—Topiramate—epilepsy syndrome	4.85e-05	0.000135	CcSEcCtD
Betaxolol—Dermatitis—Lamotrigine—epilepsy syndrome	4.85e-05	0.000135	CcSEcCtD
Betaxolol—Body temperature increased—Valproic Acid—epilepsy syndrome	4.83e-05	0.000134	CcSEcCtD
Betaxolol—Anorexia—Gabapentin—epilepsy syndrome	4.83e-05	0.000134	CcSEcCtD
Betaxolol—Anaemia—Topiramate—epilepsy syndrome	4.83e-05	0.000134	CcSEcCtD
Betaxolol—Headache—Lamotrigine—epilepsy syndrome	4.82e-05	0.000134	CcSEcCtD
Betaxolol—Decreased appetite—Pregabalin—epilepsy syndrome	4.81e-05	0.000134	CcSEcCtD
Betaxolol—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	4.77e-05	0.000133	CcSEcCtD
Betaxolol—Fatigue—Pregabalin—epilepsy syndrome	4.77e-05	0.000133	CcSEcCtD
Betaxolol—Hypotension—Gabapentin—epilepsy syndrome	4.74e-05	0.000132	CcSEcCtD
Betaxolol—Nausea—Carbamazepine—epilepsy syndrome	4.73e-05	0.000132	CcSEcCtD
Betaxolol—Pain—Pregabalin—epilepsy syndrome	4.73e-05	0.000131	CcSEcCtD
Betaxolol—Constipation—Pregabalin—epilepsy syndrome	4.73e-05	0.000131	CcSEcCtD
Betaxolol—Malaise—Topiramate—epilepsy syndrome	4.71e-05	0.000131	CcSEcCtD
Betaxolol—Vertigo—Topiramate—epilepsy syndrome	4.7e-05	0.000131	CcSEcCtD
Betaxolol—Syncope—Topiramate—epilepsy syndrome	4.69e-05	0.00013	CcSEcCtD
Betaxolol—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	4.62e-05	0.000128	CcSEcCtD
Betaxolol—Palpitations—Topiramate—epilepsy syndrome	4.62e-05	0.000128	CcSEcCtD
Betaxolol—Loss of consciousness—Topiramate—epilepsy syndrome	4.59e-05	0.000128	CcSEcCtD
Betaxolol—Insomnia—Gabapentin—epilepsy syndrome	4.59e-05	0.000128	CcSEcCtD
Betaxolol—Nausea—Lamotrigine—epilepsy syndrome	4.57e-05	0.000127	CcSEcCtD
Betaxolol—Cough—Topiramate—epilepsy syndrome	4.56e-05	0.000127	CcSEcCtD
Betaxolol—Feeling abnormal—Pregabalin—epilepsy syndrome	4.56e-05	0.000127	CcSEcCtD
Betaxolol—Paraesthesia—Gabapentin—epilepsy syndrome	4.55e-05	0.000127	CcSEcCtD
Betaxolol—Dyspnoea—Gabapentin—epilepsy syndrome	4.52e-05	0.000126	CcSEcCtD
Betaxolol—Hypersensitivity—Valproic Acid—epilepsy syndrome	4.51e-05	0.000125	CcSEcCtD
Betaxolol—Dyspepsia—Gabapentin—epilepsy syndrome	4.46e-05	0.000124	CcSEcCtD
Betaxolol—Myalgia—Topiramate—epilepsy syndrome	4.45e-05	0.000124	CcSEcCtD
Betaxolol—Chest pain—Topiramate—epilepsy syndrome	4.45e-05	0.000124	CcSEcCtD
Betaxolol—Arthralgia—Topiramate—epilepsy syndrome	4.45e-05	0.000124	CcSEcCtD
Betaxolol—Anxiety—Topiramate—epilepsy syndrome	4.43e-05	0.000123	CcSEcCtD
Betaxolol—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	4.42e-05	0.000123	CcSEcCtD
Betaxolol—Decreased appetite—Gabapentin—epilepsy syndrome	4.41e-05	0.000123	CcSEcCtD
Betaxolol—Discomfort—Topiramate—epilepsy syndrome	4.4e-05	0.000122	CcSEcCtD
Betaxolol—Urticaria—Pregabalin—epilepsy syndrome	4.39e-05	0.000122	CcSEcCtD
Betaxolol—Asthenia—Valproic Acid—epilepsy syndrome	4.39e-05	0.000122	CcSEcCtD
Betaxolol—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	4.38e-05	0.000122	CcSEcCtD
Betaxolol—Fatigue—Gabapentin—epilepsy syndrome	4.37e-05	0.000122	CcSEcCtD
Betaxolol—Body temperature increased—Pregabalin—epilepsy syndrome	4.37e-05	0.000122	CcSEcCtD
Betaxolol—Dry mouth—Topiramate—epilepsy syndrome	4.35e-05	0.000121	CcSEcCtD
Betaxolol—Constipation—Gabapentin—epilepsy syndrome	4.34e-05	0.000121	CcSEcCtD
Betaxolol—Pain—Gabapentin—epilepsy syndrome	4.34e-05	0.000121	CcSEcCtD
Betaxolol—Pruritus—Valproic Acid—epilepsy syndrome	4.33e-05	0.00012	CcSEcCtD
Betaxolol—Confusional state—Topiramate—epilepsy syndrome	4.3e-05	0.00012	CcSEcCtD
Betaxolol—Oedema—Topiramate—epilepsy syndrome	4.27e-05	0.000119	CcSEcCtD
Betaxolol—Infection—Topiramate—epilepsy syndrome	4.24e-05	0.000118	CcSEcCtD
Betaxolol—Shock—Topiramate—epilepsy syndrome	4.2e-05	0.000117	CcSEcCtD
Betaxolol—Diarrhoea—Valproic Acid—epilepsy syndrome	4.18e-05	0.000116	CcSEcCtD
Betaxolol—Nervous system disorder—Topiramate—epilepsy syndrome	4.18e-05	0.000116	CcSEcCtD
Betaxolol—Feeling abnormal—Gabapentin—epilepsy syndrome	4.18e-05	0.000116	CcSEcCtD
Betaxolol—Thrombocytopenia—Topiramate—epilepsy syndrome	4.18e-05	0.000116	CcSEcCtD
Betaxolol—Tachycardia—Topiramate—epilepsy syndrome	4.16e-05	0.000116	CcSEcCtD
Betaxolol—Skin disorder—Topiramate—epilepsy syndrome	4.14e-05	0.000115	CcSEcCtD
Betaxolol—Hyperhidrosis—Topiramate—epilepsy syndrome	4.12e-05	0.000115	CcSEcCtD
Betaxolol—Hypersensitivity—Pregabalin—epilepsy syndrome	4.07e-05	0.000113	CcSEcCtD
Betaxolol—Anorexia—Topiramate—epilepsy syndrome	4.07e-05	0.000113	CcSEcCtD
Betaxolol—Dizziness—Valproic Acid—epilepsy syndrome	4.04e-05	0.000112	CcSEcCtD
Betaxolol—Urticaria—Gabapentin—epilepsy syndrome	4.03e-05	0.000112	CcSEcCtD
Betaxolol—Body temperature increased—Gabapentin—epilepsy syndrome	4.01e-05	0.000111	CcSEcCtD
Betaxolol—Hypotension—Topiramate—epilepsy syndrome	3.99e-05	0.000111	CcSEcCtD
Betaxolol—Asthenia—Pregabalin—epilepsy syndrome	3.97e-05	0.00011	CcSEcCtD
Betaxolol—Pruritus—Pregabalin—epilepsy syndrome	3.91e-05	0.000109	CcSEcCtD
Betaxolol—Vomiting—Valproic Acid—epilepsy syndrome	3.89e-05	0.000108	CcSEcCtD
Betaxolol—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	3.89e-05	0.000108	CcSEcCtD
Betaxolol—Insomnia—Topiramate—epilepsy syndrome	3.86e-05	0.000107	CcSEcCtD
Betaxolol—Rash—Valproic Acid—epilepsy syndrome	3.86e-05	0.000107	CcSEcCtD
Betaxolol—Dermatitis—Valproic Acid—epilepsy syndrome	3.85e-05	0.000107	CcSEcCtD
Betaxolol—Headache—Valproic Acid—epilepsy syndrome	3.83e-05	0.000107	CcSEcCtD
Betaxolol—Paraesthesia—Topiramate—epilepsy syndrome	3.83e-05	0.000107	CcSEcCtD
Betaxolol—Dyspnoea—Topiramate—epilepsy syndrome	3.8e-05	0.000106	CcSEcCtD
Betaxolol—Diarrhoea—Pregabalin—epilepsy syndrome	3.78e-05	0.000105	CcSEcCtD
Betaxolol—Dyspepsia—Topiramate—epilepsy syndrome	3.75e-05	0.000104	CcSEcCtD
Betaxolol—Hypersensitivity—Gabapentin—epilepsy syndrome	3.74e-05	0.000104	CcSEcCtD
Betaxolol—Decreased appetite—Topiramate—epilepsy syndrome	3.71e-05	0.000103	CcSEcCtD
Betaxolol—Gastrointestinal disorder—Topiramate—epilepsy syndrome	3.68e-05	0.000102	CcSEcCtD
Betaxolol—Fatigue—Topiramate—epilepsy syndrome	3.68e-05	0.000102	CcSEcCtD
Betaxolol—Dizziness—Pregabalin—epilepsy syndrome	3.66e-05	0.000102	CcSEcCtD
Betaxolol—Pain—Topiramate—epilepsy syndrome	3.65e-05	0.000101	CcSEcCtD
Betaxolol—Constipation—Topiramate—epilepsy syndrome	3.65e-05	0.000101	CcSEcCtD
Betaxolol—Asthenia—Gabapentin—epilepsy syndrome	3.64e-05	0.000101	CcSEcCtD
Betaxolol—Nausea—Valproic Acid—epilepsy syndrome	3.63e-05	0.000101	CcSEcCtD
Betaxolol—Pruritus—Gabapentin—epilepsy syndrome	3.59e-05	9.97e-05	CcSEcCtD
Betaxolol—Vomiting—Pregabalin—epilepsy syndrome	3.52e-05	9.78e-05	CcSEcCtD
Betaxolol—Feeling abnormal—Topiramate—epilepsy syndrome	3.51e-05	9.77e-05	CcSEcCtD
Betaxolol—Rash—Pregabalin—epilepsy syndrome	3.49e-05	9.69e-05	CcSEcCtD
Betaxolol—Dermatitis—Pregabalin—epilepsy syndrome	3.48e-05	9.69e-05	CcSEcCtD
Betaxolol—Diarrhoea—Gabapentin—epilepsy syndrome	3.47e-05	9.65e-05	CcSEcCtD
Betaxolol—Headache—Pregabalin—epilepsy syndrome	3.46e-05	9.63e-05	CcSEcCtD
Betaxolol—Urticaria—Topiramate—epilepsy syndrome	3.39e-05	9.42e-05	CcSEcCtD
Betaxolol—Body temperature increased—Topiramate—epilepsy syndrome	3.37e-05	9.38e-05	CcSEcCtD
Betaxolol—Dizziness—Gabapentin—epilepsy syndrome	3.35e-05	9.32e-05	CcSEcCtD
Betaxolol—Nausea—Pregabalin—epilepsy syndrome	3.28e-05	9.13e-05	CcSEcCtD
Betaxolol—Vomiting—Gabapentin—epilepsy syndrome	3.22e-05	8.96e-05	CcSEcCtD
Betaxolol—Rash—Gabapentin—epilepsy syndrome	3.2e-05	8.89e-05	CcSEcCtD
Betaxolol—Dermatitis—Gabapentin—epilepsy syndrome	3.19e-05	8.88e-05	CcSEcCtD
Betaxolol—Headache—Gabapentin—epilepsy syndrome	3.18e-05	8.83e-05	CcSEcCtD
Betaxolol—Hypersensitivity—Topiramate—epilepsy syndrome	3.14e-05	8.74e-05	CcSEcCtD
Betaxolol—Asthenia—Topiramate—epilepsy syndrome	3.06e-05	8.51e-05	CcSEcCtD
Betaxolol—Pruritus—Topiramate—epilepsy syndrome	3.02e-05	8.39e-05	CcSEcCtD
Betaxolol—Nausea—Gabapentin—epilepsy syndrome	3.01e-05	8.37e-05	CcSEcCtD
Betaxolol—Diarrhoea—Topiramate—epilepsy syndrome	2.92e-05	8.12e-05	CcSEcCtD
Betaxolol—Dizziness—Topiramate—epilepsy syndrome	2.82e-05	7.84e-05	CcSEcCtD
Betaxolol—Vomiting—Topiramate—epilepsy syndrome	2.71e-05	7.54e-05	CcSEcCtD
Betaxolol—Rash—Topiramate—epilepsy syndrome	2.69e-05	7.48e-05	CcSEcCtD
Betaxolol—Dermatitis—Topiramate—epilepsy syndrome	2.69e-05	7.47e-05	CcSEcCtD
Betaxolol—Headache—Topiramate—epilepsy syndrome	2.67e-05	7.43e-05	CcSEcCtD
Betaxolol—Nausea—Topiramate—epilepsy syndrome	2.53e-05	7.05e-05	CcSEcCtD
Betaxolol—ADRB2—Signaling Pathways—CHRM3—epilepsy syndrome	2.35e-05	0.000308	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—CASP2—epilepsy syndrome	2.35e-05	0.000308	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—GRM5—epilepsy syndrome	2.35e-05	0.000308	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—UPB1—epilepsy syndrome	2.35e-05	0.000308	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—ATIC—epilepsy syndrome	2.35e-05	0.000308	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—NEU1—epilepsy syndrome	2.35e-05	0.000308	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—CX3CR1—epilepsy syndrome	2.31e-05	0.000302	CbGpPWpGaD
Betaxolol—ADRB2—GPCR downstream signaling—AVP—epilepsy syndrome	2.31e-05	0.000302	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—COX3—epilepsy syndrome	2.3e-05	0.000301	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—HSD17B4—epilepsy syndrome	2.27e-05	0.000297	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—BDKRB1—epilepsy syndrome	2.26e-05	0.000296	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—CHRM2—epilepsy syndrome	2.26e-05	0.000296	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—CX3CL1—epilepsy syndrome	2.26e-05	0.000296	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—CX3CR1—epilepsy syndrome	2.26e-05	0.000295	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—BDKRB1—epilepsy syndrome	2.21e-05	0.00029	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—CHRM2—epilepsy syndrome	2.21e-05	0.00029	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—CX3CL1—epilepsy syndrome	2.21e-05	0.00029	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—CDC42—epilepsy syndrome	2.21e-05	0.000289	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—GABBR1—epilepsy syndrome	2.2e-05	0.000288	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—GBE1—epilepsy syndrome	2.19e-05	0.000286	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—PPP1R3C—epilepsy syndrome	2.19e-05	0.000286	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—CACNA2D2—epilepsy syndrome	2.18e-05	0.000285	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—SLCO1A2—epilepsy syndrome	2.18e-05	0.000285	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—KCNB1—epilepsy syndrome	2.18e-05	0.000285	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—PFKL—epilepsy syndrome	2.18e-05	0.000285	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—SLC6A8—epilepsy syndrome	2.18e-05	0.000285	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—CDC42—epilepsy syndrome	2.16e-05	0.000283	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—GABBR1—epilepsy syndrome	2.15e-05	0.000282	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—AVP—epilepsy syndrome	2.14e-05	0.00028	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	2.13e-05	0.000279	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	2.12e-05	0.000277	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—HRH3—epilepsy syndrome	2.11e-05	0.000276	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—AVP—epilepsy syndrome	2.09e-05	0.000274	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—OPRM1—epilepsy syndrome	2.08e-05	0.000272	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—HRH3—epilepsy syndrome	2.06e-05	0.00027	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—ASAH1—epilepsy syndrome	2.06e-05	0.000269	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—OPRM1—epilepsy syndrome	2.03e-05	0.000266	CbGpPWpGaD
Betaxolol—ADRB1—GPCR downstream signaling—CCR5—epilepsy syndrome	2e-05	0.000262	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—STXBP1—epilepsy syndrome	2e-05	0.000262	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—UPB1—epilepsy syndrome	1.99e-05	0.000261	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—NEU1—epilepsy syndrome	1.99e-05	0.000261	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—ATIC—epilepsy syndrome	1.99e-05	0.000261	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—CCR3—epilepsy syndrome	1.96e-05	0.000257	CbGpPWpGaD
Betaxolol—ADRB1—GPCR downstream signaling—HTR2A—epilepsy syndrome	1.96e-05	0.000257	CbGpPWpGaD
Betaxolol—ADRB2—GPCR downstream signaling—CCR5—epilepsy syndrome	1.96e-05	0.000257	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—NT5E—epilepsy syndrome	1.95e-05	0.000255	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—ALAD—epilepsy syndrome	1.95e-05	0.000255	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—HSD17B4—epilepsy syndrome	1.92e-05	0.000251	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—CCR3—epilepsy syndrome	1.92e-05	0.000251	CbGpPWpGaD
Betaxolol—ADRB2—GPCR downstream signaling—HTR2A—epilepsy syndrome	1.92e-05	0.000251	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—NPY—epilepsy syndrome	1.91e-05	0.00025	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—ATP2A2—epilepsy syndrome	1.91e-05	0.00025	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—NPY—epilepsy syndrome	1.87e-05	0.000245	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—ATP2A2—epilepsy syndrome	1.87e-05	0.000245	CbGpPWpGaD
Betaxolol—ADRB1—GPCR downstream signaling—AGT—epilepsy syndrome	1.86e-05	0.000244	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—CACNA1A—epilepsy syndrome	1.86e-05	0.000244	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—ALDH7A1—epilepsy syndrome	1.86e-05	0.000244	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—PPP1R3C—epilepsy syndrome	1.85e-05	0.000243	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—GBE1—epilepsy syndrome	1.85e-05	0.000243	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—HSPB1—epilepsy syndrome	1.84e-05	0.000241	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—OXT—epilepsy syndrome	1.84e-05	0.000241	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—CRH—epilepsy syndrome	1.84e-05	0.000241	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—CCL3—epilepsy syndrome	1.84e-05	0.000241	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—CXCL2—epilepsy syndrome	1.84e-05	0.000241	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—ST3GAL3—epilepsy syndrome	1.82e-05	0.000238	CbGpPWpGaD
Betaxolol—ADRB2—GPCR downstream signaling—AGT—epilepsy syndrome	1.82e-05	0.000238	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—CCR5—epilepsy syndrome	1.82e-05	0.000238	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	1.81e-05	0.000237	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—CXCL2—epilepsy syndrome	1.8e-05	0.000236	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—OXT—epilepsy syndrome	1.8e-05	0.000236	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—CRH—epilepsy syndrome	1.8e-05	0.000236	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—HSPB1—epilepsy syndrome	1.8e-05	0.000236	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—CCL3—epilepsy syndrome	1.8e-05	0.000236	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—ADSL—epilepsy syndrome	1.78e-05	0.000234	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—HTR2A—epilepsy syndrome	1.78e-05	0.000233	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—CCR5—epilepsy syndrome	1.78e-05	0.000233	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—GLUL—epilepsy syndrome	1.75e-05	0.000229	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—ASAH1—epilepsy syndrome	1.74e-05	0.000228	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—HTR2A—epilepsy syndrome	1.74e-05	0.000228	CbGpPWpGaD
Betaxolol—ADRB1—GPCR downstream signaling—PRKCB—epilepsy syndrome	1.72e-05	0.000225	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—CACNA1D—epilepsy syndrome	1.72e-05	0.000225	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—TSC1—epilepsy syndrome	1.71e-05	0.000224	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—PTK2B—epilepsy syndrome	1.71e-05	0.000224	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—STXBP1—epilepsy syndrome	1.7e-05	0.000222	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—AGT—epilepsy syndrome	1.69e-05	0.000221	CbGpPWpGaD
Betaxolol—ADRB2—GPCR downstream signaling—PRKCB—epilepsy syndrome	1.68e-05	0.00022	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—TSC1—epilepsy syndrome	1.68e-05	0.00022	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—PTK2B—epilepsy syndrome	1.68e-05	0.00022	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—CCR2—epilepsy syndrome	1.67e-05	0.000218	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—SST—epilepsy syndrome	1.67e-05	0.000218	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—NTRK2—epilepsy syndrome	1.67e-05	0.000218	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—DUSP6—epilepsy syndrome	1.65e-05	0.000216	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—AGT—epilepsy syndrome	1.65e-05	0.000216	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—NT5E—epilepsy syndrome	1.65e-05	0.000216	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—ALAD—epilepsy syndrome	1.65e-05	0.000216	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—ADRA2A—epilepsy syndrome	1.63e-05	0.000214	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—CCR2—epilepsy syndrome	1.63e-05	0.000214	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—NTRK2—epilepsy syndrome	1.63e-05	0.000214	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—SST—epilepsy syndrome	1.63e-05	0.000214	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—PLAT—epilepsy syndrome	1.63e-05	0.000213	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—DUSP6—epilepsy syndrome	1.62e-05	0.000212	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—TXNRD1—epilepsy syndrome	1.61e-05	0.00021	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—ADRA2A—epilepsy syndrome	1.6e-05	0.000209	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—PLAT—epilepsy syndrome	1.59e-05	0.000208	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—CACNA1A—epilepsy syndrome	1.58e-05	0.000206	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—ALDH7A1—epilepsy syndrome	1.58e-05	0.000206	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—BDKRB2—epilepsy syndrome	1.57e-05	0.000205	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—CXCL12—epilepsy syndrome	1.57e-05	0.000205	CbGpPWpGaD
Betaxolol—ADRB1—GPCR downstream signaling—POMC—epilepsy syndrome	1.57e-05	0.000205	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—PRKCB—epilepsy syndrome	1.56e-05	0.000204	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—AQP1—epilepsy syndrome	1.56e-05	0.000204	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—IL6ST—epilepsy syndrome	1.55e-05	0.000204	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—ST3GAL3—epilepsy syndrome	1.54e-05	0.000202	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—CNR1—epilepsy syndrome	1.54e-05	0.000202	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—JUNB—epilepsy syndrome	1.54e-05	0.000202	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—CXCL12—epilepsy syndrome	1.53e-05	0.000201	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—BDKRB2—epilepsy syndrome	1.53e-05	0.000201	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—PLCB1—epilepsy syndrome	1.53e-05	0.000201	CbGpPWpGaD
Betaxolol—ADRB2—GPCR downstream signaling—POMC—epilepsy syndrome	1.53e-05	0.000201	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—PRKCB—epilepsy syndrome	1.53e-05	0.0002	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—IL6ST—epilepsy syndrome	1.52e-05	0.000199	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—ADSL—epilepsy syndrome	1.51e-05	0.000198	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—JUNB—epilepsy syndrome	1.51e-05	0.000197	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—CNR1—epilepsy syndrome	1.51e-05	0.000197	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—HTR7—epilepsy syndrome	1.5e-05	0.000197	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—PLCB1—epilepsy syndrome	1.5e-05	0.000196	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—GLUL—epilepsy syndrome	1.48e-05	0.000194	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—HTR7—epilepsy syndrome	1.47e-05	0.000192	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—HBEGF—epilepsy syndrome	1.46e-05	0.000191	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—CACNA1D—epilepsy syndrome	1.45e-05	0.00019	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—AKT3—epilepsy syndrome	1.43e-05	0.000187	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—HBEGF—epilepsy syndrome	1.43e-05	0.000187	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—POMC—epilepsy syndrome	1.42e-05	0.000186	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—KCNJ11—epilepsy syndrome	1.41e-05	0.000185	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—CHRM3—epilepsy syndrome	1.41e-05	0.000185	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—AKT3—epilepsy syndrome	1.4e-05	0.000183	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—ADAM10—epilepsy syndrome	1.4e-05	0.000183	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—CCL2—epilepsy syndrome	1.39e-05	0.000182	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—POMC—epilepsy syndrome	1.39e-05	0.000182	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—ADAM10—epilepsy syndrome	1.37e-05	0.000179	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—CCL2—epilepsy syndrome	1.36e-05	0.000178	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—TXNRD1—epilepsy syndrome	1.36e-05	0.000178	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—S100B—epilepsy syndrome	1.32e-05	0.000173	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—AQP1—epilepsy syndrome	1.32e-05	0.000173	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—SOCS3—epilepsy syndrome	1.31e-05	0.000171	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—CDC42—epilepsy syndrome	1.31e-05	0.000171	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—S100B—epilepsy syndrome	1.29e-05	0.000169	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—SOCS3—epilepsy syndrome	1.28e-05	0.000168	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—CDC42—epilepsy syndrome	1.28e-05	0.000167	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	1.27e-05	0.000166	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—AVP—epilepsy syndrome	1.26e-05	0.000166	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—AVP—epilepsy syndrome	1.24e-05	0.000162	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—HES1—epilepsy syndrome	1.2e-05	0.000157	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—CHRM3—epilepsy syndrome	1.19e-05	0.000156	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—KCNJ11—epilepsy syndrome	1.19e-05	0.000156	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—HES1—epilepsy syndrome	1.17e-05	0.000153	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—FYN—epilepsy syndrome	1.16e-05	0.000152	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—H2AFX—epilepsy syndrome	1.16e-05	0.000152	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—MEF2C—epilepsy syndrome	1.16e-05	0.000151	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—ABCG2—epilepsy syndrome	1.15e-05	0.00015	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—FYN—epilepsy syndrome	1.14e-05	0.000149	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—H2AFX—epilepsy syndrome	1.13e-05	0.000148	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—MEF2C—epilepsy syndrome	1.13e-05	0.000148	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—CYP2C19—epilepsy syndrome	1.12e-05	0.000147	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—YWHAZ—epilepsy syndrome	1.12e-05	0.000146	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—CYP11A1—epilepsy syndrome	1.11e-05	0.000146	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	1.11e-05	0.000146	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—NGF—epilepsy syndrome	1.1e-05	0.000145	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—YWHAZ—epilepsy syndrome	1.09e-05	0.000143	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	1.09e-05	0.000143	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—NGF—epilepsy syndrome	1.08e-05	0.000142	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—CCR5—epilepsy syndrome	1.07e-05	0.000141	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—HTR2A—epilepsy syndrome	1.05e-05	0.000138	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—CCR5—epilepsy syndrome	1.05e-05	0.000138	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—HTR2A—epilepsy syndrome	1.03e-05	0.000135	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—TSC2—epilepsy syndrome	9.99e-06	0.000131	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—AGT—epilepsy syndrome	9.98e-06	0.000131	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—APOE—epilepsy syndrome	9.78e-06	0.000128	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—TSC2—epilepsy syndrome	9.78e-06	0.000128	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—AGT—epilepsy syndrome	9.76e-06	0.000128	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—ABCG2—epilepsy syndrome	9.74e-06	0.000127	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—KDR—epilepsy syndrome	9.58e-06	0.000125	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—APOE—epilepsy syndrome	9.57e-06	0.000125	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—ADRA2A—epilepsy syndrome	9.56e-06	0.000125	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—BCHE—epilepsy syndrome	9.52e-06	0.000125	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—CYP2C19—epilepsy syndrome	9.49e-06	0.000124	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—CYP11A1—epilepsy syndrome	9.43e-06	0.000123	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—KDR—epilepsy syndrome	9.37e-06	0.000123	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	9.36e-06	0.000123	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—PRKCB—epilepsy syndrome	9.22e-06	0.000121	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—IL6ST—epilepsy syndrome	9.19e-06	0.00012	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—SLC2A1—epilepsy syndrome	9.09e-06	0.000119	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—PRKCB—epilepsy syndrome	9.02e-06	0.000118	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—PLCB1—epilepsy syndrome	8.99e-06	0.000118	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—IL6ST—epilepsy syndrome	8.98e-06	0.000118	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—TH—epilepsy syndrome	8.95e-06	0.000117	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	8.54e-06	0.000112	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—CYP2D6—epilepsy syndrome	8.51e-06	0.000111	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—POMC—epilepsy syndrome	8.4e-06	0.00011	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—CCL2—epilepsy syndrome	8.22e-06	0.000108	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—POMC—epilepsy syndrome	8.22e-06	0.000108	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—ADRA2A—epilepsy syndrome	8.1e-06	0.000106	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—BCHE—epilepsy syndrome	8.07e-06	0.000106	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—CCL2—epilepsy syndrome	8.04e-06	0.000105	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—SLC2A1—epilepsy syndrome	7.7e-06	0.000101	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—PLCB1—epilepsy syndrome	7.61e-06	9.97e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—TH—epilepsy syndrome	7.59e-06	9.93e-05	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—HMOX1—epilepsy syndrome	7.47e-06	9.78e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	7.47e-06	9.78e-05	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—FGF2—epilepsy syndrome	7.43e-06	9.73e-05	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—CAT—epilepsy syndrome	7.37e-06	9.65e-05	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—FGF2—epilepsy syndrome	7.27e-06	9.51e-05	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—ABCB1—epilepsy syndrome	7.17e-06	9.39e-05	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—RELA—epilepsy syndrome	6.9e-06	9.03e-05	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—MTOR—epilepsy syndrome	6.76e-06	8.85e-05	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—RELA—epilepsy syndrome	6.75e-06	8.83e-05	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—GPX1—epilepsy syndrome	6.67e-06	8.73e-05	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—MTOR—epilepsy syndrome	6.62e-06	8.66e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—HMOX1—epilepsy syndrome	6.33e-06	8.29e-05	CbGpPWpGaD
Betaxolol—ADRB1—GPCR downstream signaling—AKT1—epilepsy syndrome	6.28e-06	8.22e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—CAT—epilepsy syndrome	6.25e-06	8.18e-05	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—CASP3—epilepsy syndrome	6.22e-06	8.14e-05	CbGpPWpGaD
Betaxolol—ADRB2—GPCR downstream signaling—AKT1—epilepsy syndrome	6.14e-06	8.04e-05	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—CASP3—epilepsy syndrome	6.08e-06	7.97e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—ABCB1—epilepsy syndrome	6.08e-06	7.96e-05	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—JUN—epilepsy syndrome	6.04e-06	7.91e-05	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—JUN—epilepsy syndrome	5.91e-06	7.74e-05	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—MMP9—epilepsy syndrome	5.88e-06	7.7e-05	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—AGT—epilepsy syndrome	5.85e-06	7.66e-05	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—MMP9—epilepsy syndrome	5.75e-06	7.53e-05	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—APOE—epilepsy syndrome	5.73e-06	7.5e-05	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—AKT1—epilepsy syndrome	5.7e-06	7.46e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—GPX1—epilepsy syndrome	5.65e-06	7.4e-05	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—AKT1—epilepsy syndrome	5.58e-06	7.3e-05	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—SRC—epilepsy syndrome	5.42e-06	7.09e-05	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—SRC—epilepsy syndrome	5.3e-06	6.94e-05	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—VEGFA—epilepsy syndrome	5.28e-06	6.91e-05	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—VEGFA—epilepsy syndrome	5.16e-06	6.76e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—AGT—epilepsy syndrome	4.95e-06	6.49e-05	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—POMC—epilepsy syndrome	4.92e-06	6.44e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—APOE—epilepsy syndrome	4.85e-06	6.35e-05	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—ALB—epilepsy syndrome	4.49e-06	5.87e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—POMC—epilepsy syndrome	4.17e-06	5.46e-05	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—PTGS2—epilepsy syndrome	3.93e-06	5.14e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—ALB—epilepsy syndrome	3.8e-06	4.98e-05	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—AKT1—epilepsy syndrome	3.37e-06	4.41e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—PTGS2—epilepsy syndrome	3.33e-06	4.35e-05	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—AKT1—epilepsy syndrome	3.29e-06	4.31e-05	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—AKT1—epilepsy syndrome	1.97e-06	2.58e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—AKT1—epilepsy syndrome	1.67e-06	2.19e-05	CbGpPWpGaD
